Form 4: Atlassian Co-Founder Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Atlassian CEO and Co-Founder Michael Cannon-Brookes sold 7,665 shares of Class A Common Stock for approximately $1.15 million under a pre-arranged 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, Atlassian's CEO, Co-Founder, Director, and 10% Owner, sold a total of 7,665 shares of Class A Common Stock.
- The sales occurred on October 16, 2025, at weighted-average prices ranging from $148.9357 to $155.81 per share.
- The estimated total value of the shares sold is approximately $1,150,000.
- These transactions were executed under a Rule 10b5-1 trading plan established on February 20, 2025.
- Following these transactions, Michael Cannon-Brookes indirectly beneficially owns 398,580 shares of Class A Common Stock through the Cannon-Brookes Head Trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reports routine insider selling under a pre-established 10b5-1 trading plan, which is a common practice and does not inherently reflect positively or negatively on the company's operational performance or future prospects.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment rather than a reaction to new, undisclosed negative information.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake in the company.
Future Outlook
The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.
Industry Context
Insider selling, particularly by a CEO and co-founder, is a common occurrence in the technology industry, often for diversification, liquidity, or tax planning purposes. The use of a Rule 10b5-1 plan is a standard practice to execute such sales in a pre-scheduled manner, mitigating concerns about trading on material non-public information.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | Michael Cannon-Brookes adopted a Rule 10b5-1 trading plan on February 20, 2025, to facilitate the systematic sale of company shares. | 02/20/2025 | The adoption of a 10b5-1 plan enhances transparency and provides an affirmative defense against insider trading allegations by pre-scheduling trades. |
Related Party Transactions
- Shares are held indirectly by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, which is a related party to Michael Cannon-Brookes.
Stakeholder Impact
- Shareholders: May view the insider selling as a signal, though the 10b5-1 plan mitigates concerns about opportunistic selling. It reduces the direct equity alignment of a key executive.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 10/16/2025 | Date of reported transactions (sales of Class A Common Stock). |
| 10/17/2025 | Date the Form 4 was signed. |
Recommendation
holdWhile insider selling can sometimes be a negative signal, these transactions were executed under a pre-arranged 10b5-1 plan, which suggests a planned divestment for personal financial management rather than a reaction to adverse company-specific news. Given the routine nature of such plans for high-net-worth individuals, this filing alone does not provide sufficient new information to warrant a change in investment recommendation. Investors should 'hold' and monitor broader company performance and market trends.
Keywords
Atlassian, TEAM, Michael Cannon-Brookes, Insider Selling, Form 4, SEC Filing, 10b5-1 Plan, Stock Sale, CEO, Co-Founder
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.